arrow
T

Theodore S. Lawrence

university of michigan
H指数:102
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ISGylation of γH2AX retains MDC1 and facilitates homologous recombination repair causing radioresistance in esophageal adenocarcinoma

ISG化修饰的γH2AX保留MDC1并促进同源重组修复,从而导致食管腺癌的放射抵抗。

2026-03-090
OAAI
Digital twins for in vivo metabolic flux estimations in patients with brain cancer

脑癌患者体内代谢流估算的数字孪生技术

2025-12-010
OAAI
Integrating scRNA-seq and13C-tracing delineates metabolic heterogeneity in the glioblastoma tumor microenvironment

整合单细胞RNA测序和13C示踪技术揭示了胶质母细胞瘤肿瘤微环境中的代谢异质性

2025-11-010
OAAI
Rewiring of cortical glucose metabolism fuels human brain cancer growth

皮层葡萄糖代谢的重编程为人类脑癌的生长提供能量。

2025-11-010
OAAI
THY1 Mediates Treatment Resistance in H3K7M Pediatric Tumors and is Therapeutically Targetable

THY1 介导了 H3K7M 儿童肿瘤的治疗抵抗,并且是可进行治疗性靶向的。

2025-11-010
OAAI
Parotid-Sparing vs. Conventional Whole Brain Radiotherapy: A Multi-Institutional Randomized Clinical Trial

腮腺保护与常规全脑放射治疗:一项多中心随机临床试验

2025-10-270
PRE
Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review

胃肠道腹癌的再放疗临床实践:一项国际再放疗协作组(ReCOG)系统评价

2025-08-130
OAAI
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition

H3K27M弥漫性中线胶质瘤是同源重组缺陷,并通过PARP抑制对放疗和NK细胞介导的抗肿瘤免疫敏感

2025-04-100
PRE
A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From an Interim Analysis

一项多参数磁共振成像引导的高剂量适应性放射疗法与同步替莫唑胺联合治疗新诊断胶质母细胞瘤的二期研究:中期分析结果

2025-03-080
PRE
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus (vol 14, pg 134, 2024)
2025-03-010
PRE
Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Cancer
2024-12-010
PRE
REWIRING OF CORTICAL GLUCOSE METABOLISM FUELS HUMAN BRAIN CANCER GROWTH
2024-11-110
PRE